Vaccinex, Inc. (VCNX): Revenue
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$601.0K
Year ended 2024-12-31
-12.6%
3-year compound annual growth
+2.8%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $601.0K | +5.4% | 2025-04-15, From 2024-01-01 |
| 2023-12-31 | $570.0K | +107.3% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $275.0K | -69.4% | 2024-04-25, From 2022-01-01 |
| 2021-12-31 | $900.0K | +44.0% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $625.0K | +19.5% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $523.0K | -27.8% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $724.0K | +704.4% | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | $90.0K | n/a | 2019-03-13, From 2017-01-01 |